Natural antisense and non-coding RNA transcripts as drug targets
US10472627B2 · kind B2 · utility
0Cited by
241References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 26, 2017 |
| Grant date | Nov 12, 2019 |
| Priority date | — |
| Expiry date | Oct 17, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2330/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Small interfering RNA (siRNA) knock down antisense transcripts, and regulate the expression of their sense partners. This regulation can either be discordant (antisense knockdown results in sense transcript elevation) or concordant (antisense knockdown results in concomitant sense transcript reduction).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.